VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRQRProQR Therapeutics N.V.
$1.72$181M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRQRQuarterly Financials

ProQR Therapeutics N.V. (PRQR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ProQR Therapeutics N.V. (PRQR) quarterly income statement — complete revenue, gross profit & net income history

PRQR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue2.07M4.64M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M654K
Revenue Growth %-54.27%7.83%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%----
Cost of Goods Sold705.41K672.63K000000000000000000
COGS % of Revenue34.14%14.48%------------------
Gross Profit1.36M3.97M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M654K
Gross Margin %65.86%85.52%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-69.88%-7.79%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%----
Operating Expenses15.23M13.01M14.2M16.07M15.34M14.39M12.56M9.9M12.53M9.55M8.76M10.05M10.09M13.67M20.71M16.86M18.27M17.77M15.71M13.86M
OpEx % of Revenue737.24%280.16%487.1%420.91%339.35%334.06%326.8%157.1%281.46%290.86%639.49%808.85%1447.06%1128.9%2332.32%1638.58%1484.57%4002.7%1357.08%2118.81%
Selling, General & Admin3.21M3.18M3.12M4.82M3.23M3.91M3.28M3.01M3.45M4.75M3.31M4.14M4.03M2.97M5.36M5.41M4.91M5.32M4.59M4.12M
SG&A % of Revenue155.34%68.52%107%126.17%71.56%90.85%85.43%47.79%77.57%144.64%241.97%333.47%577.62%245.42%603.49%525.95%398.7%1197.3%396.46%630.28%
Research & Development12.02M9.83M11.08M11.41M12.32M10.61M9.41M7.05M9.28M7.73M5.45M5.91M6.06M10.7M15.35M11.45M13.37M12.46M11.12M9.73M
R&D % of Revenue581.9%211.65%380.1%298.87%272.69%246.37%244.96%111.78%208.61%235.48%397.52%475.38%869.44%883.48%1728.83%1112.63%1085.87%2805.41%960.62%1488.53%
Other Operating Expenses000-158K-222K-136K-138K-156K-210K-1000K01000-10000
Operating Income-13.87M-9.04M-11.28M-12.25M-10.82M-10.08M-8.72M-3.6M-8.07M-6.27M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M-13.2M
Operating Margin %-671.37%-194.65%-387.1%-320.91%-239.34%-234.06%-226.8%-57.1%-181.46%-190.86%-539.49%-708.85%-1347.06%-1028.9%-2232.32%-1538.58%-1384.57%-3902.7%-1257.08%-2018.81%
Operating Income Growth %-28.27%10.33%-29.46%-240.25%-33.94%-60.83%-17.93%59.14%14%49.7%62.71%44.35%44.91%28.09%-36.18%-19.91%-40.82%-48.52%-34.02%-293.06%
EBITDA-13.17M-8.37M-10.61M-11.57M-10.14M-9.41M-8.03M-2.89M-7.38M-5.54M-6.75M-8.22M-8.84M-12.26M-19.21M-15.24M-16.47M-16.78M-14.01M-12.6M
EBITDA Margin %-637.24%-180.16%-364.08%-303.22%-224.34%-218.48%-208.9%-45.82%-165.93%-168.7%-492.63%-661.06%-1268.29%-1012.72%-2163.4%-1481.15%-1338.26%-3778.38%-1210.1%-1926.76%
EBITDA Growth %-29.89%11.09%-32.2%-300.62%-37.3%-69.86%-18.95%64.84%16.47%54.83%64.87%46.09%46.34%26.9%-37.09%-20.95%-43.6%-52.3%-37.23%-345.42%
D&A (Non-Cash Add-back)705.41K672.63K671K675K678K671K688K711K691K728K642K594K549K196K612K591K570K552K544K602K
EBIT-13.87M-9.04M-11.01M-12.25M-10.82M-6.49M-8.85M-3.6M-8.07M-1.02M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M-13.2M
Net Interest Income215.49K117.88K0192K455K704K469K513K488K1.1M363K470K-544K-1.23M599K1.16M-822K-909K266K-2.46M
Interest Income215.49K117.88K0192K455K704K469K515.59K490.87K824.29K373.56K468.97K00599K1.16M0-890K266K0
Interest Expense00000002.59K2.87K-276.71K10.56K-1.03K544K1.23M00822K19K02.46M
Other Income/Expense270.37K204.07K278K88K737K776K608K708K420K790K2.01M876K534K-840K-3.41M2.37M2.93M-890K-477K-2.5M
Pretax Income-13.6M-8.84M-11.01M-12.16M-10.08M-9.3M-8.11M-2.89M-7.66M-5.48M-5.38M-7.94M-8.86M-13.3M-23.23M-13.46M-14.11M-18.22M-15.03M-15.7M
Pretax Margin %-658.29%-190.25%-377.56%-318.6%-223.04%-216.04%-210.98%-45.87%-172.02%-166.81%-392.63%-638.38%-1270.44%-1098.27%-2616.55%-1308.36%-1146.22%-4103.15%-1298.27%-2400.61%
Income Tax0991018K000-200K3K5K41K42K0069K20K7K22K35K53K
Effective Tax Rate %0%-0.01%0%-0.15%0%0%0%6.92%-0.04%-0.09%-0.76%-0.53%0%0%-0.3%-0.15%-0.05%-0.12%-0.23%-0.34%
Net Income-13.6M-8.84M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.71M-7.99M-8.93M-13.3M-23.32M-13.7M-14.11M-18.22M-15.05M-15.75M
Net Margin %-658.29%-190.27%-377.56%-319.07%-223.04%-216.04%-210.98%-42.7%-172.09%-166.96%-416.79%-643.04%-1281.64%-1098.02%-2625.9%-1331.39%-1146.14%-4103.83%-1299.4%-2407.65%
Net Income Growth %-34.96%5.04%-35.74%-352.41%-31.61%-69.71%-42%66.32%14.27%58.77%75.51%41.66%36.69%27.02%-54.97%12.99%-11.91%-37.86%-14.16%-282.93%
Net Income (Continuing)-13.6M-8.84M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.42M-7.98M-8.86M-13.3M-23.3M-13.48M-14.12M-18.24M-15.07M-15.75M
Discontinued Operations00000000000000000000
Minority Interest00000000000-290K-306K-384K-381K-395K-612K-604K-585K-563K
EPS (Diluted)-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22-0.24
EPS Growth %-30%22.64%-0.7%-263.64%-5.93%-61.53%-40.85%66.6%4.45%51.36%79.26%52.95%50.6%46.15%-54.55%12.5%20%0%15.38%-191.97%
EPS (Basic)-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22-0.24
Diluted Shares Outstanding105.36M103.01M110.06M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M66.15M
Basic Shares Outstanding105.36M103.01M105.35M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M66.15M
Dividend Payout Ratio--------------------